13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Boehringer Ingelheim, Roche Forge Partnership for Inflammatory Bowel Diseases December 18, 2017 Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017 Cellect Is Moving To Trade Exclusively On The June 8, 2017
Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017
